Findings in PPARα-null mice [8] and MHC-PPARα mice [9] suggest that the lack of PPARα or increase in its level leads to cardiac hypertrophy and dilated cardiomyopathy (DCM). This evidence concerns the gene PPARA and dilated cardiomyopathy.